HLA-C and neoplasm: Antigens processed within the proteasome of tumor cells are presented on major histocompatibility antigen (MHC) class I molecules of tumor cell as tumor antigen peptides that CTLs recognize, thus triggering CTL-mediated cytotoxicity.